Global Drug Discovery Informatics Market is expected to reach US $ 5.27 BN By Forecast year 2028

September 02 08:40 2021
Global Drug Discovery Informatics Market is expected to reach US $ 5.27 BN By Forecast year 2028
Drug Discovery Informatics – Global Market Outlook (2020-2028)
Drug Discovery Informatics Market size is expected to grow from US $ 2.24 BN in 2020 to US $ 5.27 BN by 2028, at a CAGR of 11.3%.

The market report “Drug Discovery Informatics Market by Types (In-House and Outsourced), Solutions (Software and Services), Functions (Clinical Trial Data Management, Docking, Library & Database Preparation, Molecular Modelling, Screening & Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) Characterization, and Sequencing and Target Data Analysis), Informatics Workflows (Discovery Informatics and Development Informatics), Modalities (Cloud Based Systems and In Campus Platform), Applications (Drug Discovery and Drug Development), End Users (Academic Institutes, Biotechnology Companies, Contract Research Organization (CROs), Government Organizations, Hospital, Pharmaceutical Companies and University) and Region – Forecast to 2028”. The drug discovery informatics market is growing at a CAGR of 11.3% by 2028, owing to the rising research & development (R&D) expenditure and increasing use of informatics in drug discovery.

Browse the complete report with 234 data tables and 39+ figures here:

Based on end user, the pharmaceutical companies segment is estimated to have largest market share during the study period.On the basis of end user, the market is categorised into academic institutes, biotechnology companies, contract research organization (CROs), government organizations, hospital, pharmaceutical companies and university. Pharmaceutical companies segment is estimated to have largest market share during the study period as they employ the informatics software widely for various processes like lead & target identification, compound screening and pre-clinical R&D which are responsible for the large market share.

Based on informatics workflow, the discovery informatics segment is expected to dominate the market share during the forecast period.On the basis of informatics workflow, the market is segmented into discovery informatics and development informatics. Discovery informatics segment is expected to contribute largely to the market value in the forecast period due to the focus on precision medicines development. Moreover, governments in several countries are also promoting the application of discovery informatics, which leads to the growth of the segment.

By geography, Asia Pacific is expected to dominate the marketOn the basis of geography, the market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. Asia Pacific is expected to grow at a high CAGR during the forecast period owing to the rising number of contact research organizations, rapid growth in biopharmaceutical and pharmaceutical industry and the presence of liberal regulations compared to other regions.

We offer a 15% customization to be added within the report at no extra cost. To know more post your query here:

The key players in this market are Albany Molecular Research Inc., Certara, L.P., Charles River, Selvita, Collaborative Drug Discovery, Inc, Dassault Systèmes, GVK Biosciences Private Limited, IBM Corporation, Infosys Limited, Insilico Medicine, IO Informatics, Inc., Jubilant Life Sciences Ltd., OpenEye Scientific Software, PerkinElmer Inc., Schrödinger, LLC and Thermo Fisher Scientific.

The Global Drug Discovery Informatics Market is majorly driven by rising research & development (R&D) expenditure, growing support for research, especially in the area of rare diseases, and the increasing use of informatics in drug discovery.The sequencing and target data analysis segment is growing at a highest CAGR owing to increased application for sequencing analysis for the new drug entity and ease of handling of information from different sources and different domains. North America dominated with a significant market share due to the factors such as presence of well-established CROs, rising R&D expenditure by pharmaceutical and biopharmaceutical companies in the region. Asia Pacific market is growing at a highest CAGR owing to the rapid growth in the pharmaceutical and biopharmaceutical industry, rising number of CROs, and the presence of less-stringent regulations for drug discovery processes.

About Stratistics Market Research Consulting Pvt Ltd

Stratistics Market Research Pvt Ltd is a business research firm offering market reports across the industries. Our advanced techniques and tools in identifying the market trends helps in shaping today’s business landscape. Our syndicate and custom reports specialize in identifying new market opportunities. Our team of consultants help you to formulate a confident business strategy by providing competitive advantage. Our research services cover Market Entry Strategy, Strategic Benchmarking and Competitive Landscaping.

We have a core research team with analysts across the industry verticals to serve our varied customers such as technology suppliers, manufacturers, distributors, end-users, consulting companies, investment firms and research institutes.

Media Contact
Company Name: Stratistics Market Research Consulting
Contact Person: Kumar
Email: Send Email
Phone: +1-301-202-5929
Country: India